Search Results - "de Morais, Ana Luiza Gomes"

Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission by Smaletz, Oren, Ismael, Gustavo, Del Pilar Estevez-Diz, Maria, Nascimento, Ivana L O, de Morais, Ana Luiza Gomes, Cunha-Junior, Geraldo Felício, Azevedo, Sergio J, Alves, Venancio A, Moro, Ana Maria, Yeda, Fernanda P, Dos Santos, Mariana Lopes, Majumder, Indrani, Hoffman, Eric W

“…To investigate the efficacy and safety of hu3S193, a humanized anti-Lewis-Y monoclonal antibody, as a consolidation strategy in patients with…”
Get more information

T-cell-engaging Therapy for Solid Tumors by de Miguel, Maria, Umana, Pablo, Gomes de Morais, Ana Luiza, Moreno, Victor, Calvo, Emiliano

“…T-cell engagers (TCE) are a rapidly evolving novel group of treatments that have in common the concurrent engagement of a T-cell surface molecule and a tumoral…”
Get full text

New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors by Gomes de Morais, Ana Luiza, Cerdá, Sara, de Miguel, Maria

“…Purpose of Review Even though checkpoint inhibitors have become a recent milestone for the treatment of many different tumor types, eventually, most part of…”
Get full text

Comparative assessment of different radiological criteria to identify paradoxical hyperprogression (HPD) to IO drugs by Gomes de Morais, Ana Luiza, Cardenas, Jose M, de Miguel Luken, Maria Jose, Boni, Valentina, Moreno, Irene, Ao, Gerileto, Liu, Run Han, de Hoyos, Fernando Bergaz, Cubillo, Antonio, Calvo, Emiliano

“…Abstract only e15229 Background: HPD is a new pattern of response consisting of accelerated tumor growth due to immunotherapy (5%-20% of pts on IO drugs). The…”
Get full text

Anti-LeY monoclonal antibody (mAb) hu3S193 as consolidation therapy for patients (pts) with relapsing platinum sensitive ovarian cancer (OC) after achieving a second complete response (2CR) by Smaletz, Oren, Ismael, Gustavo, Estevez-Diz, Maria Del Pilar, Nascimento, Ivana Lucia Oliveira, Wiermann, Ana Luiza Gomes de Morais, Cunha, Geraldo Felicio, Azevedo, Sergio J, Alves, Venâncio A, Moro, Ana M, Yeda, Fernanda Perez, dos Santos, Mariana Lopes, Majumder, Indrani, Hoffman, Eric W.

“…Abstract only e17039 Background: Lewis-Y (LeY) antigen is a blood group related antigen expressed in 75% of OC. hu3S193 is a humanized anti-LeY IgG1 mAb with…”
Get full text